We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+8.13%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$516M
AUM Growth
+$18M
(+3.6%)
Cap. Flow
-$7.13M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
10.08%
Holding
773
New
214
Increased
142
Reduced
148
Closed
268
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corpay
CPAY
|
+$5.69M |
| 2 |
Amgen
AMGN
|
+$5.43M |
| 3 |
Intuit
INTU
|
+$5.33M |
| 4 |
Humana
HUM
|
+$5.13M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$4.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$5.01M |
| 2 |
Exelon
EXC
|
+$4.97M |
| 3 |
Comcast
CMCSA
|
+$4.93M |
| 4 |
State Street
STT
|
+$4.2M |
| 5 |
Johnson Controls International
JCI
|
+$4.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.82% |
| 2 | Consumer Discretionary | 14.92% |
| 3 | Financials | 13.7% |
| 4 | Healthcare | 11.59% |
| 5 | Industrials | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
NiSource
NI
$21.3B
| – | – |
-32,982
| Closed | -$730K |
|
627
NVIDIA
NVDA
$4.86T
| – | – |
-227,720
| Closed | -$608K |
|
|
NVO
628
Novo Nordisk
NVO
$208B
| – | – |
-97,100
| Closed | -$1.74M |
|
629
Novartis
NVS
$297B
| – | – |
-2,306
| Closed | -$150K |
|
630
News Corp Class A
NWSA
$14.9B
| – | – |
-22,933
| Closed | -$263K |
|
631
O-I Glass
OI
$1.1B
| – | – |
-1,400
| Closed | -$24K |
|
632
Opko Health
OPK
$985M
| – | – |
-1
| Closed | – |
|
633
Old Republic International
ORI
$10.5B
| – | – |
-92,900
| Closed | -$1.76M |
|
634
Ovintiv
OVV
$17.3B
| – | – |
-26,620
| Closed | -$1.56M |
|
635
Pan American Silver
PAAS
$18.2B
| – | – |
-10,500
| Closed | -$158K |
|
|
PARA
636
DELISTED
Paramount Global Class B
PARA
| – | – |
-6,700
| Closed | -$426K |
|
637
PBF Energy
PBF
$8.57B
| – | – |
-2,534
| Closed | -$71K |
|
638
Pacira BioSciences
PCRX
$1.04B
| – | – |
-2,401
| Closed | -$78K |
|
639
Precigen
PGEN
$2.24B
| – | – |
-31,913
| Closed | -$769K |
|
640
Pultegroup
PHM
$24.1B
| – | – |
-48,003
| Closed | -$882K |
|
641
Polaris
PII
$3.82B
| – | – |
-94
| Closed | -$8K |
|
642
Dave & Buster's
PLAY
$377M
| – | – |
-2,000
| Closed | -$113K |
|
643
Perrigo
PRGO
$1.4B
| – | – |
-17,233
| Closed | -$1.43M |
|
644
Primerica
PRI
$9.98B
| – | – |
-3,200
| Closed | -$221K |
|
645
Phillips 66
PSX
$84.9B
| – | – |
-9,296
| Closed | -$803K |
|
646
PayPal
PYPL
$48.9B
| – | – |
-90,418
| Closed | -$3.57M |
|
647
RPC Inc
RES
$1.24B
| – | – |
-17,468
| Closed | -$346K |
|
648
Royal Gold
RGLD
$16.8B
| – | – |
-14,500
| Closed | -$919K |
|
649
RH
RH
$3.13B
| $0 | ﹤0.01% |
2
-296
| -99% | -$9.15K |
|
650
Raymond James Financial
RJF
$33.8B
| – | – |
-300
| Closed | -$14K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2017 Portfolio in Review
As of Q1 2017, Seven Eight Capital held 773 positions worth $516M, up 3.6% from $498M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Seven Eight Capital's Q1 2017 filing shows 214 new, 142 increased, 148 reduced and 268 closed positions. Its largest new stake was Corpay: 36,300 shares worth $5.5M. The largest sale was Texas Instruments, an estimated $5.01M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
- Seven Eight Capital's largest Q1 2017 buy was Corpay: 36,300 shares worth $5.5M.
- Seven Eight Capital added most to Amgen in Q1 2017, an estimated $5.43M increase.
- Seven Eight Capital's biggest Q1 2017 reduction was Comcast, cutting an estimated $4.93M.
- Seven Eight Capital fully exited Texas Instruments in Q1 2017, selling an estimated $5.01M.
- Seven Eight Capital's ten largest holdings make up 10% of its $516M portfolio in Q1 2017.
- Seven Eight Capital opened 214 new positions and closed 268 in Q1 2017.
- Seven Eight Capital's portfolio value rose 3.6% quarter-over-quarter to $516M.
Based on Seven Eight Capital's 13F filing for Q1 2017, filed 15 May 2017.